advanced search

Welcome: Guest

log in

Premium Company Profile: Discovery Laboratories

Publication Date November 2007
Publisher Datamonitor
Product Type Report
Pages 45
ISBN Number not applicable
Product Code DAT08646
Price

£265.00
approximately: $468 | €336

PDFBuy Now
PRINT £315 ($556 | €399)Buy Now
Order above formats by FAXOrder by FAX

Summary

Discovery Labs' main focus is to discover and develop novel drugs for the treatment of respiratory diseases. The company has proprietary surfactant technology known as Surfactant Replacement Therapies (SRT) that is used to produce a series of respiratory therapies for patients in the Neonatal Intensive Care Unit, Pediatric Intensive Care Unit, critical care unit and other hospital settings.

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Discovery Labs is focused on the discovery and development of proprietary surfactant technology as Surfactant Replacement Therapies (SRT) for the treatment of respiratory disorders and diseases. In April 2006, the company received a second Approvable Letter from the FDA for Discovery Labs' lead product candidate.



Discovery Labs did not record any revenues during the fiscal year 2006, primarily due to the restructuring of its corporate partnership with Esteve in late 2004. Prior to 2006, the company's sole contributor to revenue growth during 2002-2005 was licensing.



Discovery Labs' sole contributor to sales growth out to 2010 will be the sales of Surfaxin. Revenues from Surfaxin is expected to increase to $58 million in 2010, representing an absolute growth of +$58 million during the period 2006-2010.

Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Content

  • Table Of Contents
    • Overview
    • Catalyst
    • Summary
    • Company Structure
    • Company Overview And Key Facts
    • Business Description
    • History
    • Locations And Subsidiaries
    • Company Financials
    • Stock Market Performance
    • P&L
    • Balance Sheet
    • Cash Flow
    • Business Segment Performance
    • Products & Services
    • Pipeline Products
    • Ac Forecast Product Sales
    • Competitors And Strategic Business Relationships
    • Key Competitors
    • Key Suppliers
    • Shareholding Structure
    • Strategy
    • Company View
    • Corporate Strategy
    • Swot Analysis
    • Overview
    • Strengths
    • Weaknesses
    • Opportunities
    • Threats
    • Value Chain Analysis
    • Overview
    • Discovery And Product Development
    • Manufacturing
    • Scorecard
    • Overview
    • Scorecard Analysis
    • Key Employees
  • List Of Key Employees
    • Key Employee Biographies
    • Financial And Operational Overview
    • Financial And Operational Overview
  • Appendix
    • Ask The Analyst
    • Datamonitor Consulting
    • Disclaimer
  • Table Of Figures
    • Figure 1: Discovery Laboratories - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
    • Figure 2: Discovery Laboratories - Key Strategic Revenues, 2006-2010 ($ Mn)
  • Table Of Tables
    • Table 1: Discovery Laboratories - Key Facts
    • Table 2: Discovery Laboratories - Locations And Subsidiaries
    • Table 3: Discovery Laboratories - Year-End Share Price And Market Capitalization, 2002-2006 ($)
    • Table 4: Discovery Laboratories - Key Events Impacting Share Price Performance
    • Table 5: Discovery Laboratories - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
    • Table 6: Discovery Laboratories - Operating Cost Ratio Analysis, 2002-2006 (% Of Total Revenues)
    • Table 7: Discovery Laboratories - Balance Sheet, 2002-2006 ($ Mn)
    • Table 8: Discovery Laboratories - Cash Flow, 2002-2006 ($ Mn)
    • Table 9: Discovery Laboratories - Revenue Breakdown, 2002-2006 ($ Mn)
    • Table 10: Discovery Laboratories - Collaboration Pipeline Products
    • Table 11: Discovery Laboratories - Forecast Sales, 2006-2010 ($ Mn)
    • Table 12: Discovery Laboratories - Key Competitors
    • Table 13: Discovery Laboratories - Key Suppliers
    • Table 14: Discovery Laboratories - Key Shareholders
    • Table 15: Discovery Laboratories - Swot Analysis Summary
    • Table 16: Discovery Laboratories - Value Chain Analysis
    • Table 17: Discovery Laboratories - Scorecard
    • Table 18: Discovery Laboratories - Key Employees
    • Table 19: Discovery Laboratories - Financial And Operational Overview